|
|
|
|
|
|
Management Team
David G. Watumull, President and CEO
More than twenty years experience as a biotechnology industry executive, analyst, and
investment banker. Co-founder of Cardax Pharmaceuticals and co-inventor of initial Cardax
technology. As CEO of Hawaii Biotech, led efforts that raised more than $25 million in equity
financing and $30 million in grant funding.
|
|
Fredric J. Pashkow, M.D., Chief Medical Officer, EVP
Former Vice President U.S. Medical Affairs for the Cardiovascular-Thrombosis Therapeutic
Area at Sanofi-Aventis; Responsible for medicals affairs and clinical trials for drugs with
more than $5 billion in cardiovascular sales. Ten years at the Cleveland Clinic, former
member of the Board of Directors at Hawaii Biotech.
|
|
Thomas H. Goodin, Ph.D., Senior Vice President, Pre-Clinical and Clinical Operations
More than 20 years of experience in mid-size and large pharma, biotech, and academic
medicine. Responsible for operational oversight of clinical research programs for market
leading anti-platelet and anti-thrombotic therapies. Directed and managed pre-clinical
research and clinical development programs of NCEs.
|
|
|
|
|
|
